Establishing a sovereign domestic supply ensures reliable and affordable life-saving treatments by removing the reliance on unstable global supply chains.
Developing process technology to recover critical isotopes from unconventional sources.
entX is feeding the growth of the Theragnostic and Targeted Alpha Therapy cancer treatment markets.
Process design is underway with an aim to deliver a prototype demonstrator.
Early-stage concept development and design for the extraction and purification of 228-Ra and 228-Th.
Process design and demonstration plant in partnership with Tellus Holdings Ltd.
